Wang Zhe, Li Minghuan, Huang Yong, Ma Li, Zhu Hui, Kong Li, Yu Jinming
School of Medicine, Shandong University, Jinan, Shandong, China.
Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China.
Onco Targets Ther. 2018 May 4;11:2509-2517. doi: 10.2147/OTT.S154385. eCollection 2018.
The proportion of central pulmonary adenocarcinoma (ADC) in central-type lung cancer has been gradually increasing due to the overall increasing incidence of pulmonary ADC. But the clinical and radiological characteristics of central ADCs remain unclear. In this study, we compared the clinical and radiological characteristics of central ADCs with those of small cell lung cancers (SCLCs) and squamous cell carcinomas (SQCCs) and investigated the impact of these characteristics on patients' treatment response.
The medical records of 302 consecutive patients with central lung cancer from July 2014 to September 2016 were retrospectively reviewed. There were 99 patients with ADC, 95 with SQCC and 108 with SCLC. Computed tomography images were interpreted by two radiologists. Treatment response was determined by Response Evaluation Criteria In Solid Tumors 1.1.
Univariate analyses found that younger age, female sex, no history of smoking, higher levels of carcinoembryonic antigen (CEA), contralateral hilum lymphadenopathy, contralateral lung metastasis, pleural nodules and pleural metastasis to the interlobular fissure were significantly correlated with central ADC. Multivariate logistic regression analyses revealed that compared with central SQCC, female sex, younger age, no history of smoking, higher levels of CEA and contralateral hilum lymphadenopathy were the significantly independent indicators of central pulmonary ADC. Furthermore, compared with central SCLC, younger age, higher levels of CEA and cytokeratin 19 fragment (Cyfra21-1), lower levels of neuron-specific enolase, pleural nodules and lack of vascular involvement were significantly associated with central ADC. In 85 central ADC patients who received first-line platinum-based chemotherapy, both univariate and multivariate logistic regression analyses revealed that pulmonary emphysema had a negative correlation with treatment response (odds ratio=8.04, =0.02).
Our study revealed that central pulmonary ADCs exhibited more aggressive clinical and radiological characteristics. Pulmonary emphysema was an independent and negative indicator for treatment response of central ADC.
由于肺腺癌总体发病率上升,中央型肺腺癌(ADC)在中央型肺癌中的比例逐渐增加。但中央型ADC的临床和影像学特征仍不明确。在本研究中,我们比较了中央型ADC与小细胞肺癌(SCLC)和鳞状细胞癌(SQCC)的临床和影像学特征,并研究了这些特征对患者治疗反应的影响。
回顾性分析2014年7月至2016年9月连续收治的302例中央型肺癌患者的病历。其中腺癌99例,鳞状细胞癌95例,小细胞肺癌108例。计算机断层扫描图像由两名放射科医生解读。治疗反应根据实体瘤疗效评价标准1.1确定。
单因素分析发现,年龄较小、女性、无吸烟史、癌胚抗原(CEA)水平较高、对侧肺门淋巴结肿大、对侧肺转移、胸膜结节及胸膜转移至叶间裂与中央型ADC显著相关。多因素logistic回归分析显示,与中央型SQCC相比,女性、年龄较小、无吸烟史、CEA水平较高及对侧肺门淋巴结肿大是中央型肺腺癌的显著独立指标。此外,与中央型SCLC相比,年龄较小、CEA和细胞角蛋白19片段(Cyfra21-1)水平较高、神经元特异性烯醇化酶水平较低、胸膜结节及无血管受累与中央型ADC显著相关。在85例接受一线铂类化疗的中央型ADC患者中,单因素和多因素logistic回归分析均显示肺气肿与治疗反应呈负相关(比值比=8.04,P=0.02)。
我们的研究表明,中央型肺腺癌具有更具侵袭性的临床和影像学特征。肺气肿是中央型ADC治疗反应的独立负性指标。